Nombre del producto:(1S,3S)-N-hydroxy-3-[methyl(7H-pyrrolo[2,3-d]-pyrimidin-4-yl)amino]cyclobutane-1-carboxamide

IUPAC Name:N-hydroxy-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclobutane-1-carboxamide

CAS:2407868-83-9
Fórmula molecular:C12H15N5O2
Pureza:95%+
Número de catálogo:CM577768
Peso molecular:261.29

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2407868-83-9
Fórmula molecular:C12H15N5O2
Punto de fusión:-
Código de sonrisas:CN(C1CC(C1)C(=O)NO)C1=C2C=CNC2=NC=N1
Densidad:
Número de catálogo:CM577768
Peso molecular:261.29
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Related Products